1
|
Lerner A, Lee AJX, Yan H, Van Griethuysen J, Bartlett AD, Veli M, Jiang Y, Luong M, Naban N, Kane C, Conibear J, Papadatos-Pastos D, Ahmad T, Chao D, Anand G, Asghar US. A Multicentric, Retrospective, Real-world Study on Immune-related Adverse Events in Patients with Advanced Non-small Cell Lung Cancers Treated with Pembrolizumab Monotherapy. Clin Oncol (R Coll Radiol) 2024; 36:193-199. [PMID: 38246850 DOI: 10.1016/j.clon.2024.01.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2023] [Revised: 12/05/2023] [Accepted: 01/12/2024] [Indexed: 01/23/2024]
Abstract
AIMS We present 7 years of clinical experience with single-agent pembrolizumab immune checkpoint inhibitor immunotherapy in non-small cell lung cancers (NSCLC) from four UK cancer centres. MATERIALS AND METHODS This multi-institutional retrospective cohort study included 226 metastatic NSCLC patients. Outcomes were number and severity of immune-related adverse events (irAEs), median progression-free survival (mPFS) and median overall survival (mOS). RESULTS Within our cohort, 119/226 (53%) patients developed irAEs. Of these, 54/119 (45%) experienced irAEs affecting two or more organ systems. The most common irAEs were diarrhoea and rash. The development of an irAE was associated with better mOS (20.7 versus 8.0 months; P < 0.001) and mPFS (12.0 versus 3.9 months; P < 0.001). The development of grade 3/4 toxicities was associated with worse outcomes compared with the development of grade 1/2 toxicities (mOS 6.1 months versus 25.2 months, P < 0.01; mPFS 5.6 months versus 19.3 months, P = 0.01, respectively). Females had a higher proportion of reported grade 3/4 toxicities (13/44 [29.5%] versus 10/74 [13.5%], P = 0.03). Using a multiple Cox regression model, the presence of irAEs was associated with a better overall survival (hazard ratio = 0.42, 95% confidence interval 0.29-0.61; P < 0.01) and better PFS (hazard ratio 0.38, 95% confidence interval 0.27-0.53; P < 0.001). CONCLUSION In this multicentre retrospective cohort study, the development of at least one irAE was associated with significantly longer mPFS and mOS; however, more severe grade 3 and 4 irAEs were associated with worse outcomes. Delayed-onset irAEs, after the 3-month timepoint, were associated with better clinical outcomes.
Collapse
Affiliation(s)
- A Lerner
- North Middlesex University Hospital, London, UK
| | - A J X Lee
- UCL Cancer Institute, University College London, London, UK; University College London Hospitals NHS Foundation Trust, London, UK
| | - H Yan
- University College London Hospitals NHS Foundation Trust, London, UK
| | | | | | - M Veli
- University College London Hospitals NHS Foundation Trust, London, UK; Princess Alexandra Hospital, Harlow, UK
| | - Y Jiang
- University College London Hospitals NHS Foundation Trust, London, UK
| | - M Luong
- University College London Hospitals NHS Foundation Trust, London, UK
| | - N Naban
- North Middlesex University Hospital, London, UK
| | - C Kane
- Mount Vernon Cancer Centre, Northwood, UK
| | | | - D Papadatos-Pastos
- University College London Hospitals NHS Foundation Trust, London, UK; Princess Alexandra Hospital, Harlow, UK
| | - T Ahmad
- University College London Hospitals NHS Foundation Trust, London, UK
| | - D Chao
- Royal Free London Hospital, London, UK
| | - G Anand
- North Middlesex University Hospital, London, UK
| | - U S Asghar
- The Royal Marsden NHS Foundation Trust, Sutton, UK; Concr LTD, Cambridge, UK; Croydon University Hospital, Thornton Heath, UK.
| |
Collapse
|
2
|
Crous PW, Osieck ER, Shivas RG, Tan YP, Bishop-Hurley SL, Esteve-Raventós F, Larsson E, Luangsa-Ard JJ, Pancorbo F, Balashov S, Baseia IG, Boekhout T, Chandranayaka S, Cowan DA, Cruz RHSF, Czachura P, De la Peña-Lastra S, Dovana F, Drury B, Fell J, Flakus A, Fotedar R, Jurjević Ž, Kolecka A, Mack J, Maggs-Kölling G, Mahadevakumar S, Mateos A, Mongkolsamrit S, Noisripoom W, Plaza M, Overy DP, Piątek M, Sandoval-Denis M, Vauras J, Wingfield MJ, Abell SE, Ahmadpour A, Akulov A, Alavi F, Alavi Z, Altés A, Alvarado P, Anand G, Ashtekar N, Assyov B, Banc-Prandi G, Barbosa KD, Barreto GG, Bellanger JM, Bezerra JL, Bhat DJ, Bilański P, Bose T, Bozok F, Chaves J, Costa-Rezende DH, Danteswari C, Darmostuk V, Delgado G, Denman S, Eichmeier A, Etayo J, Eyssartier G, Faulwetter S, Ganga KGG, Ghosta Y, Goh J, Góis JS, Gramaje D, Granit L, Groenewald M, Gulden G, Gusmão LFP, Hammerbacher A, Heidarian Z, Hywel-Jones N, Jankowiak R, Kaliyaperumal M, Kaygusuz O, Kezo K, Khonsanit A, Kumar S, Kuo CH, Læssøe T, Latha KPD, Loizides M, Luo SM, Maciá-Vicente JG, Manimohan P, Marbach PAS, Marinho P, Marney TS, Marques G, Martín MP, Miller AN, Mondello F, Moreno G, Mufeeda KT, Mun HY, Nau T, Nkomo T, Okrasińska A, Oliveira JPAF, Oliveira RL, Ortiz DA, Pawłowska J, Pérez-De-Gregorio MÀ, Podile AR, Portugal A, Privitera N, Rajeshkumar KC, Rauf I, Rian B, Rigueiro-Rodríguez A, Rivas-Torres GF, Rodriguez-Flakus P, Romero-Gordillo M, Saar I, Saba M, Santos CD, Sarma PVSRN, Siquier JL, Sleiman S, Spetik M, Sridhar KR, Stryjak-Bogacka M, Szczepańska K, Taşkın H, Tennakoon DS, Thanakitpipattana D, Trovão J, Türkekul I, van Iperen AL, van 't Hof P, Vasquez G, Visagie CM, Wingfield BD, Wong PTW, Yang WX, Yarar M, Yarden O, Yilmaz N, Zhang N, Zhu YN, Groenewald JZ. Fungal Planet description sheets: 1478-1549. Persoonia 2023; 50:158-310. [PMID: 38567263 PMCID: PMC10983837 DOI: 10.3767/persoonia.2023.50.05] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 04/01/2023] [Accepted: 05/10/2023] [Indexed: 04/04/2024]
Abstract
Novel species of fungi described in this study include those from various countries as follows: Australia, Aschersonia mackerrasiae on whitefly, Cladosporium corticola on bark of Melaleuca quinquenervia, Penicillium nudgee from soil under Melaleuca quinquenervia, Pseudocercospora blackwoodiae on leaf spot of Persoonia falcata, and Pseudocercospora dalyelliae on leaf spot of Senna alata. Bolivia, Aspicilia lutzoniana on fully submersed siliceous schist in high-mountain streams, and Niesslia parviseta on the lower part and apothecial discs of Erioderma barbellatum on a twig. Brazil, Cyathus bonsai on decaying wood, Geastrum albofibrosum from moist soil with leaf litter, Laetiporus pratigiensis on a trunk of a living unknown hardwood tree species, and Scytalidium synnematicum on dead twigs of unidentified plant. Bulgaria, Amanita abscondita on sandy soil in a plantation of Quercus suber. Canada, Penicillium acericola on dead bark of Acer saccharum, and Penicillium corticola on dead bark of Acer saccharum. China, Colletotrichum qingyuanense on fruit lesion of Capsicum annuum. Denmark, Helminthosphaeria leptospora on corticioid Neohypochnicium cremicolor. Ecuador (Galapagos), Phaeosphaeria scalesiae on Scalesia sp. Finland, Inocybe jacobssonii on calcareous soils in dry forests and park habitats. France, Cortinarius rufomyrrheus on sandy soil under Pinus pinaster, and Periconia neominutissima on leaves of Poaceae. India, Coprinopsis fragilis on decaying bark of logs, Filoboletus keralensis on unidentified woody substrate, Penicillium sankaranii from soil, Physisporinus tamilnaduensis on the trunk of Azadirachta indica, and Poronia nagaraholensis on elephant dung. Iran, Neosetophoma fici on infected leaves of Ficus elastica. Israel, Cnidariophoma eilatica (incl. Cnidariophoma gen. nov.) from Stylophora pistillata. Italy, Lyophyllum obscurum on acidic soil. Namibia, Aureobasidium faidherbiae on dead leaf of Faidherbia albida, and Aureobasidium welwitschiae on dead leaves of Welwitschia mirabilis. Netherlands, Gaeumannomycella caricigena on dead culms of Carex elongata, Houtenomyces caricicola (incl. Houtenomyces gen. nov.) on culms of Carex disticha, Neodacampia ulmea (incl. Neodacampia gen. nov.) on branch of Ulmus laevis, Niesslia phragmiticola on dead standing culms of Phragmites australis, Pseudopyricularia caricicola on culms of Carex disticha, and Rhodoveronaea nieuwwulvenica on dead bamboo sticks. Norway, Arrhenia similis half-buried and moss-covered pieces of rotting wood in grass-grown path. Pakistan, Mallocybe ahmadii on soil. Poland, Beskidomyces laricis (incl. Beskidomyces gen. nov.) from resin of Larix decidua ssp. polonica, Lapidomyces epipinicola from sooty mould community on Pinus nigra, and Leptographium granulatum from a gallery of Dendroctonus micans on Picea abies. Portugal, Geoglossum azoricum on mossy areas of laurel forest areas planted with Cryptomeria japonica, and Lunasporangiospora lusitanica from a biofilm covering a biodeteriorated limestone wall. Qatar, Alternaria halotolerans from hypersaline sea water, and Alternaria qatarensis from water sample collected from hypersaline lagoon. South Africa, Alfaria thamnochorti on culm of Thamnochortus fraternus, Knufia aloeicola on Aloe gariepensis, Muriseptatomyces restionacearum (incl. Muriseptatomyces gen. nov.) on culms of Restionaceae, Neocladosporium arctotis on nest of cases of bag worm moths (Lepidoptera, Psychidae) on Arctotis auriculata, Neodevriesia scadoxi on leaves of Scadoxus puniceus, Paraloratospora schoenoplecti on stems of Schoenoplectus lacustris, Tulasnella epidendrea from the roots of Epidendrum × obrienianum, and Xenoidriella cinnamomi (incl. Xenoidriella gen. nov.) on leaf of Cinnamomum camphora. South Korea, Lemonniera fraxinea on decaying leaves of Fraxinus sp. from pond. Spain, Atheniella lauri on the bark of fallen trees of Laurus nobilis, Halocryptovalsa endophytica from surface-sterilised, asymptomatic roots of Salicornia patula, Inocybe amygdaliolens on soil in mixed forest, Inocybe pityusarum on calcareous soil in mixed forest, Inocybe roseobulbipes on acidic soils, Neonectria borealis from roots of Vitis berlandieri × Vitis rupestris, Sympoventuria eucalyptorum on leaves of Eucalyptus sp., and Tuber conchae from soil. Sweden, Inocybe bidumensis on calcareous soil. Thailand, Cordyceps sandindaengensis on Lepidoptera pupa, buried in soil, Ophiocordyceps kuchinaraiensis on Coleoptera larva, buried in soil, and Samsoniella winandae on Lepidoptera pupa, buried in soil. Taiwan region (China), Neophaeosphaeria livistonae on dead leaf of Livistona rotundifolia. Türkiye, Melanogaster anatolicus on clay loamy soils. UK, Basingstokeomyces allii (incl. Basingstokeomyces gen. nov.) on leaves of Allium schoenoprasum. Ukraine, Xenosphaeropsis corni on recently dead stem of Cornus alba. USA, Nothotrichosporon aquaticum (incl. Nothotrichosporon gen. nov.) from water, and Periconia philadelphiana from swab of coil surface. Morphological and culture characteristics for these new taxa are supported by DNA barcodes. Citation: Crous PW, Osieck ER, Shivas RG, et al. 2023. Fungal Planet description sheets: 1478-1549. Persoonia 50: 158- 310. https://doi.org/10.3767/persoonia.2023.50.05.
Collapse
Affiliation(s)
- P W Crous
- Westerdijk Fungal Biodiversity Institute, P.O. Box 85167, 3508AD Utrecht, The Netherlands
- Department of Biochemistry, Genetics and Microbiology, Forestry and Agricultural Biotechnology Institute (FABI), University of Pretoria, Pretoria, South Africa
| | - E R Osieck
- Jkvr. C.M. van Asch van Wijcklaan 19, 3972 ST Driebergen-Rijsenburg, Netherlands
| | - R G Shivas
- Centre for Crop Health, University of Southern Queensland, Toowoomba 4350, Queensland, Australia
| | - Y P Tan
- Queensland Plant Pathology Herbarium, Department of Agriculture and Fisheries, Dutton Park 4102, Queensland, Australia
| | - S L Bishop-Hurley
- Queensland Plant Pathology Herbarium, Department of Agriculture and Fisheries, Dutton Park 4102, Queensland, Australia
| | - F Esteve-Raventós
- Universidad de Alcalá, Facultad de Ciencias, Departamento de Ciencias de la Vida (Botánica). 28805 Alcalá de Henares, Madrid, Spain
| | - E Larsson
- Biological and Environmental Sciences, University of Gothenburg, and Gothenburg Global Biodiversity Centre, Box 461, SE40530 Göteborg, Sweden
| | - J J Luangsa-Ard
- BIOTEC, National Science and Technology Development Agency (NSTDA), 111 Thailand Science Park, Phahonyothin Road, Khlong Nueng, Khlong Luang, Pathum Thani, 12120, Thailand
| | - F Pancorbo
- Sociedad Micológica de Madrid, Real Jardín Botánico, C/ Claudio Moyano 1, 28014 Madrid, Spain
| | - S Balashov
- EMSLAnalytical, Inc., 200 Route 130 North, Cinnaminson, NJ 08077 USA
| | - I G Baseia
- Departamento de Botânica e Zoologia, Universidade Federal do Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil
| | - T Boekhout
- College of Science, King Saud University, P.O. Box 2455, Riyadh-11451, Saudi Arabia
| | - S Chandranayaka
- Department of Studies in Biotechnology, University of Mysore, Manasagangotri, Mysore - 570006, Karnataka, India
| | - D A Cowan
- Centre for Microbial Ecology and Genomics, Department of Biochemistry, Genetics and Microbiology, University of Pretoria, Private Bag X20, Hatfield 0028, Pretoria, South Africa
| | - R H S F Cruz
- Centro das Ciências Biológicas e da Saúde, Universidade Federal do Oeste da Bahia, Barreiras, 47810-047, Brazil
| | - P Czachura
- W. Szafer Institute of Botany, Polish Academy of Sciences, Lubicz 46, PL-31-512 Kraków, Poland
| | | | - F Dovana
- Via Quargnento, 17, 15029 Solero, Italy
| | - B Drury
- Queensland College of Teachers, Mount Alvernia College, Kedron 4031, Queensland, Australia
| | - J Fell
- Rosenstiel School of Marine and Atmospheric Sciences, University of Miami, Key Biscayne, Florida, USA
| | - A Flakus
- W. Szafer Institute of Botany, Polish Academy of Sciences, Lubicz 46, PL-31-512 Kraków, Poland
| | - R Fotedar
- Department of Genetic Engineering, Biotechnology Centre, Ministry of Environment, Doha, State of Qatar
| | - Ž Jurjević
- EMSLAnalytical, Inc., 200 Route 130 North, Cinnaminson, NJ 08077 USA
| | - A Kolecka
- Westerdijk Fungal Biodiversity Institute, P.O. Box 85167, 3508AD Utrecht, The Netherlands
| | - J Mack
- Ottawa Research & Development Centre, Agriculture &AgriFood Canada, 960 Carling Ave., Ottawa, Ontario, Canada, K1A 0C6
| | - G Maggs-Kölling
- Gobabeb Namib Research Institute, Walvis Bay, Namibia
- Unit for Environmental Sciences and Management, North-West University, P. Bag X1290, Potchefstroom, 2520, South Africa
| | - S Mahadevakumar
- Forest Pathology Department, Forest Health Division, KSCSTE-Kerala Forest Research Institute, Peechi - 680653, Thrissur, Kerala, India
- Botanical Survey of India, Andaman and Nicobar Regional Center, Haddo - 744102, Port Blair, South Andaman, India
| | - A Mateos
- Sociedad Micológica Extremeña, C/ Sagitario 14, 10001 Cáceres, Spain
| | - S Mongkolsamrit
- BIOTEC, National Science and Technology Development Agency (NSTDA), 111 Thailand Science Park, Phahonyothin Road, Khlong Nueng, Khlong Luang, Pathum Thani, 12120, Thailand
| | - W Noisripoom
- BIOTEC, National Science and Technology Development Agency (NSTDA), 111 Thailand Science Park, Phahonyothin Road, Khlong Nueng, Khlong Luang, Pathum Thani, 12120, Thailand
| | - M Plaza
- C/ La Angostura, 20, 11370 Los Barrios, Cádiz, Spain
| | - D P Overy
- Ottawa Research & Development Centre, Agriculture &AgriFood Canada, 960 Carling Ave., Ottawa, Ontario, Canada, K1A 0C6
| | - M Piątek
- W. Szafer Institute of Botany, Polish Academy of Sciences, Lubicz 46, PL-31-512 Kraków, Poland
| | - M Sandoval-Denis
- Westerdijk Fungal Biodiversity Institute, P.O. Box 85167, 3508AD Utrecht, The Netherlands
| | - J Vauras
- Biological Collections of Åbo Akademi University, Biodiversity Unit, Herbarium, FI-20014 University of Turku, Finland
| | - M J Wingfield
- Department of Biochemistry, Genetics and Microbiology, Forestry and Agricultural Biotechnology Institute (FABI), University of Pretoria, Pretoria, South Africa
| | - S E Abell
- Australian Tropical Herbarium, James Cook University, Smithfield 4878, Queensland, Australia
| | - A Ahmadpour
- Higher Education Centre of Shahid Bakeri, Urmia University, Miyandoab, Iran
| | - A Akulov
- Department of Mycology and Plant Resistance, V. N. Karazin Kharkiv National University, Maidan Svobody 4, 61022 Kharkiv, Ukraine
| | - F Alavi
- Higher Education Centre of Shahid Bakeri, Urmia University, Miyandoab, Iran
| | - Z Alavi
- Higher Education Centre of Shahid Bakeri, Urmia University, Miyandoab, Iran
| | - A Altés
- Universidad de Alcalá, Facultad de Ciencias, Departamento de Ciencias de la Vida (Botánica). 28805 Alcalá de Henares, Madrid, Spain
| | - P Alvarado
- ALVALAB, Dr. Fernando Bongera st., Severo Ochoa bldg. S1.04, 33006 Oviedo, Spain
| | - G Anand
- National Fungal Culture Collection of India (NFCCI), Biodiversity and Palaeobiology (Fungi) group, MACS Agharkar Research Institute, GG Agharkar Road, Pune, Maharashtra State 411004, India
| | - N Ashtekar
- National Fungal Culture Collection of India (NFCCI), Biodiversity and Palaeobiology (Fungi) group, MACS Agharkar Research Institute, GG Agharkar Road, Pune, Maharashtra State 411004, India
| | - B Assyov
- Institute of Biodiversity and Ecosystem Research, Bulgarian Academy of Sciences, 2 Gagarin Str., 1113 Sofia, Bulgaria
| | - G Banc-Prandi
- Laboratory for Biological Geochemistry, School of Architecture, Civil and Environmental Engineering, École Polytechnique Fédérale de Lausanne (EPFL), 1015, Lausanne, Switzerland
| | - K D Barbosa
- Programa de Pós-Graduação em Sistemática e Evolução, Centro de Biociências, Universidade Federal do Rio Grande do Norte, Av. Senador Salgado Filho, 3000, 59072-970, Natal, Rio Grande do Norte, Brazil
| | - G G Barreto
- Department of Biology, State University of Feira de Santana, Transnordestina s/n, Novo Horizonte, 44036-900, Feira de Santana, Brazil
| | - J-M Bellanger
- CEFE, CNRS, Université de Montpellier, EPHE, IRD, INSERM, Campus CNRS, 1919 Route de Mende, F-34293 Montpellier, France
| | - J L Bezerra
- Federal University of Pernambuco, Pernambuco, Brazil
| | - D J Bhat
- College of Science, King Saud University, P.O. Box 2455, Riyadh-11451, Saudi Arabia
| | - P Bilański
- Department of Forest Ecosystems Protection, University of Agriculture in Krakow, Al. 29 Listopada 46, 31-425 Krakow, Poland
| | - T Bose
- Department of Biochemistry, Genetics and Microbiology, Forestry and Agricultural Biotechnology Institute (FABI), University of Pretoria, Pretoria, South Africa
| | - F Bozok
- Department of Biology, Faculty ofArts and Science, Osmaniye KorkutAta University, 80000 Osmaniye, Türkiye
| | - J Chaves
- Universidad San Francisco de Quito USFQ, Colegio de Ciencias Biológicas y Ambientales, Diego de Robles s/n, 170901, Quito, Ecuador
- San Francisco State University, Department of Biology, 1600 Holloway Av, San Francisco CA 94132, USA
| | - D H Costa-Rezende
- Department of Biology, State University of Feira de Santana, Transnordestina s/n, Novo Horizonte, 44036-900, Feira de Santana, Brazil
| | - C Danteswari
- Department of Plant Sciences, University of Hyderabad, Hyderabad, Telangana, India
| | - V Darmostuk
- W. Szafer Institute of Botany, Polish Academy of Sciences, Lubicz 46, PL-31-512 Kraków, Poland
| | - G Delgado
- Eurofins Built Environment, 6110 W. 34th St, Houston, TX 77092, USA
| | - S Denman
- Forest Research, Alice Holt Lodge, Farnham, Surrey, UK
| | - A Eichmeier
- Mendeleum - Institute of Genetics, Mendel University in Brno, Valticka 334, Lednice, 69144, Czech Republic
| | - J Etayo
- Navarro Villoslada 16, 3º cha., E-31003 Pamplona, Navarra, Spain
| | - G Eyssartier
- Institut de systématique, évolution, biodiversité (UMR 7205-MNHN, CNRS, Sorbonne Université, EPHE, Université des Antilles), 45 rue Buffon, F-75005 Paris, France
| | - S Faulwetter
- Department of Geology, University of Patras, 26504 Rio Patras, Greece
| | - K G G Ganga
- Department of Botany, University of Calicut, Kerala, 673 635, India
| | - Y Ghosta
- Department of Plant Protection, Faculty of Agriculture, Urmia University, Urmia, Iran
| | - J Goh
- Fungal Research Team, Microbial Research Department, Nakdonggang National Institute of Biological Resources, Korea
| | - J S Góis
- Programa de Pós-Graduação em Sistemática e Evolução, Centro de Biociências, Universidade Federal do Rio Grande do Norte, Av. Senador Salgado Filho, 3000, 59072-970, Natal, Rio Grande do Norte, Brazil
| | - D Gramaje
- Instituto de Ciencias de la Vid y del Vino (ICVV), CSIC - Universidad de La Rioja - Gobierno de La Rioja, Ctra. LO-20 Salida 13, 26007 Logroño, Spain
| | - L Granit
- Department of Plant Pathology and Microbiology, The Robert H. Smith Faculty of Agriculture Food and Environment, The Hebrew University of Jerusalem, Rehovot, Israel & Interuniversity Institute of Marine Sciences, Eilat, Israel
| | - M Groenewald
- Westerdijk Fungal Biodiversity Institute, P.O. Box 85167, 3508AD Utrecht, The Netherlands
| | - G Gulden
- Natural History Museum, University of Oslo, PO Box 1172 Blindern, NO-0318 Oslo, Norway
| | - L F P Gusmão
- Department of Biology, State University of Feira de Santana, Transnordestina s/n, Novo Horizonte, 44036-900, Feira de Santana, Brazil
| | - A Hammerbacher
- Department of Zoology and Entomology, Forestry and Agricultural Biotechnology Institute (FABI), University of Pretoria, South Africa
| | - Z Heidarian
- Higher Education Centre of Shahid Bakeri, Urmia University, Miyandoab, Iran
| | - N Hywel-Jones
- Zhejiang BioAsia Institute of Life Sciences, Pinghu 314200, Zhejiang, People's Republic of China
| | - R Jankowiak
- Department of Forest Ecosystems Protection, University of Agriculture in Krakow, Al. 29 Listopada 46, 31-425 Krakow, Poland
| | - M Kaliyaperumal
- CAS in Botany, University of Madras, Chennai, Tamil Nadu, India
| | - O Kaygusuz
- Department of Plant and Animal Production, Atabey Vocational School, Isparta University of Applied Sciences, 32670 Isparta, Türkiye
| | - K Kezo
- CAS in Botany, University of Madras, Chennai, Tamil Nadu, India
| | - A Khonsanit
- BIOTEC, National Science and Technology Development Agency (NSTDA), 111 Thailand Science Park, Phahonyothin Road, Khlong Nueng, Khlong Luang, Pathum Thani, 12120, Thailand
| | - S Kumar
- Forest Pathology Department, Forest Health Division, KSCSTE-Kerala Forest Research Institute, Peechi - 680653, Thrissur, Kerala, India
| | - C H Kuo
- Department of Plant Medicine, National Chiayi University, 300 Syuefu Road, Chiayi City 60004, Taiwan
| | - T Læssøe
- Globe Institute/Department of Biology, University of Copenhagen, Universitetsparken 15, 2100 Copenhagen Ø, Denmark
| | - K P D Latha
- Department of Botany, University of Calicut, Kerala, 673 635, India
| | | | - S M Luo
- University of Sydney, Plant Breeding Institute, 107 Cobbitty Rd, Cobbitty, New South Wales, Australia
| | - J G Maciá-Vicente
- Plant Ecology and Nature Conservation, Wageningen University & Research, P.O. Box 47, 6700 AA Wageningen, The Netherlands
- Department of Microbial Ecology, Netherlands Institute for Ecology (NIOO-KNAW), P.O. Box 50, 6700 AB Wageningen, The Netherlands
| | - P Manimohan
- Department of Botany, University of Calicut, Kerala, 673 635, India
| | - P A S Marbach
- Recôncavo da Bahia Federal University, Bahia, Brazil
| | - P Marinho
- Departamento de Biologia Celular e Genética, Universidade Federal do Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil
| | - T S Marney
- Queensland Plant Pathology Herbarium, Department of Agriculture and Fisheries, Dutton Park 4102, Queensland, Australia
| | - G Marques
- CITAB-University of Trás-os-Montes and Alto Douro, 5000-801 Vila Real, Portugal
| | - M P Martín
- Departamento de Micología, Real Jardín Botánico RJB-CSIC, Plaza de Murillo 2, 28014 Madrid, Spain
| | - A N Miller
- University of Illinois Urbana-Champaign, Illinois Natural History Survey, 1816 South Oak Street, Champaign, Illinois, 61820, USA
| | - F Mondello
- Via B. da Neocastro, 26, 98123 Messina, Italy
| | - G Moreno
- Universidad de Alcalá, Facultad de Ciencias, Departamento de Ciencias de la Vida (Botánica). 28805 Alcalá de Henares, Madrid, Spain
| | - K T Mufeeda
- Forest Pathology Department, Forest Health Division, KSCSTE-Kerala Forest Research Institute, Peechi - 680653, Thrissur, Kerala, India
| | - H Y Mun
- Fungal Research Team, Microbial Research Department, Nakdonggang National Institute of Biological Resources, Korea
| | - T Nau
- Institute of Ecology, Evolution and Diversity, Goethe University Frankfurt, Max-von-Laue-Str. 13, 60438 Frankfurt am Main, Germany
| | - T Nkomo
- Department of Biochemistry, Genetics and Microbiology, Forestry and Agricultural Biotechnology Institute (FABI), University of Pretoria, Pretoria, South Africa
| | - A Okrasińska
- Institute of Evolutionary Biology, Faculty of Biology, Biological and Chemical Research Centre, University of Warsaw, ul. Zwirki i Wigury 101, 02-089 Warsaw, Poland
| | | | - R L Oliveira
- Programa de Pós-Graduação em Sistemática e Evolução, Centro de Biociências, Universidade Federal do Rio Grande do Norte, Av. Senador Salgado Filho, 3000, 59072-970, Natal, Rio Grande do Norte, Brazil
| | - D A Ortiz
- Universidad San Francisco de Quito USFQ, Galapagos Science Center GSC, San Cristóbal 200101, Galápagos, Ecuador
| | - J Pawłowska
- Institute of Evolutionary Biology, Faculty of Biology, Biological and Chemical Research Centre, University of Warsaw, ul. Zwirki i Wigury 101, 02-089 Warsaw, Poland
| | | | - A R Podile
- Department of Plant Sciences, University of Hyderabad, Hyderabad, Telangana, India
| | - A Portugal
- Centre for Functional Ecology, Department of Life Sciences, University of Coimbra, 3004-531 Coimbra, Portugal
- Fitolab - Laboratory for Phytopathology, Instituto Pedro Nunes, 3030-199 Coimbra, Portugal
| | - N Privitera
- Associazione Micologica Bresadola Gruppo di Catania, Via Macallè 18, I-95125 Catania, Italy
| | - K C Rajeshkumar
- National Fungal Culture Collection of India (NFCCI), Biodiversity and Palaeobiology (Fungi) group, MACS Agharkar Research Institute, GG Agharkar Road, Pune, Maharashtra State 411004, India
| | - I Rauf
- Department of Plant Sciences, Quaid-i-Azam University, 45320, Islamabad, Pakistan
| | - B Rian
- Natural History Museum, University of Oslo, PO Box 1172 Blindern, NO-0318 Oslo, Norway
| | | | - G F Rivas-Torres
- Universidad San Francisco de Quito USFQ, Colegio de Ciencias Biológicas y Ambientales, Diego de Robles s/n, 170901, Quito, Ecuador
- Geography, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
- Universidad San Francisco de Quito USFQ, Galapagos Science Center GSC, San Cristóbal 200101, Galápagos, Ecuador
| | - P Rodriguez-Flakus
- W. Szafer Institute of Botany, Polish Academy of Sciences, Lubicz 46, PL-31-512 Kraków, Poland
| | | | - I Saar
- Institute of Ecology and Earth Sciences, University of Tartu, J. Liivi Street 2, 50409 Tartu, Estonia
| | - M Saba
- Department of Plant Sciences, Quaid-i-Azam University, 45320, Islamabad, Pakistan
| | - C D Santos
- Federal Institute of the Sertão Pernambucano, Pernambuco, Brazil
| | - P V S R N Sarma
- Department of Plant Sciences, University of Hyderabad, Hyderabad, Telangana, India
| | - J L Siquier
- Interdisciplinary Ecology Group, University of the Balearic Islands, crtra. to Valldemossa km 7.5, 07122 Mallorca, Spain
| | - S Sleiman
- Project Manager, Council of Environment, Akkar, North Lebanon
| | - M Spetik
- Mendeleum - Institute of Genetics, Mendel University in Brno, Valticka 334, Lednice, 69144, Czech Republic
| | - K R Sridhar
- Department of Biosciences, Mangalore University, Mangalagangotri, Mangalore - 574199, Karnataka, India
| | - M Stryjak-Bogacka
- W. Szafer Institute of Botany, Polish Academy of Sciences, Lubicz 46, PL-31-512 Kraków, Poland
| | - K Szczepańska
- Department of Botany and Plant Ecology, Wrocław University of Environmental and Life Sciences, pl. Grunwaldzki 24a, PL-50-363 Wrocław, Poland
| | - H Taşkın
- Department of Horticulture, Faculty of Agriculture, Cukurova University, 01330 Adana, Türkiye
| | - D S Tennakoon
- Faculty of Science, Department of Biology, Chiang Mai University, 50200, Chiang Mai, Thailand
| | - D Thanakitpipattana
- BIOTEC, National Science and Technology Development Agency (NSTDA), 111 Thailand Science Park, Phahonyothin Road, Khlong Nueng, Khlong Luang, Pathum Thani, 12120, Thailand
| | - J Trovão
- Centre for Functional Ecology, Department of Life Sciences, University of Coimbra, 3004-531 Coimbra, Portugal
| | - I Türkekul
- Department of Biology, Faculty of Science and Arts, Gaziosmanpaşa University, 60010 Tokat, Türkiye
| | - A L van Iperen
- Westerdijk Fungal Biodiversity Institute, P.O. Box 85167, 3508AD Utrecht, The Netherlands
| | - P van 't Hof
- Universidad San Francisco de Quito USFQ, Colegio de Ciencias Biológicas y Ambientales, Diego de Robles s/n, 170901, Quito, Ecuador
- Universidad San Francisco de Quito USFQ, Galapagos Science Center GSC, San Cristóbal 200101, Galápagos, Ecuador
| | - G Vasquez
- Department of Biology, Geology and Environmental Science, University of Catania, Via A. Longo 19, I-95125 Catania, Italy
| | - C M Visagie
- Department of Biochemistry, Genetics and Microbiology, Forestry and Agricultural Biotechnology Institute (FABI), University of Pretoria, Pretoria, South Africa
| | - B D Wingfield
- Department of Biochemistry, Genetics and Microbiology, Forestry and Agricultural Biotechnology Institute (FABI), University of Pretoria, Pretoria, South Africa
| | - P T W Wong
- University of Sydney, Plant Breeding Institute, 107 Cobbitty Rd, Cobbitty, New South Wales, Australia
| | - W X Yang
- College of Plant Protection, Hebei Agricultural University, 289 Lingyusi Street, Baoding, Hebei Province, China
| | - M Yarar
- Department of Biotechnology, Institute of Natural and Applied Sciences, Cukurova University, 01330 Adana, Türkiye
| | - O Yarden
- Department of Plant Pathology and Microbiology, The Robert H. Smith Faculty of Agriculture Food and Environment, The Hebrew University of Jerusalem, Rehovot, Israel & Interuniversity Institute of Marine Sciences, Eilat, Israel
| | - N Yilmaz
- Department of Biochemistry, Genetics and Microbiology, Forestry and Agricultural Biotechnology Institute (FABI), University of Pretoria, Pretoria, South Africa
| | - N Zhang
- College of Plant Protection, Hebei Agricultural University, 289 Lingyusi Street, Baoding, Hebei Province, China
| | - Y N Zhu
- College of Plant Protection, Hebei Agricultural University, 289 Lingyusi Street, Baoding, Hebei Province, China
| | - J Z Groenewald
- Westerdijk Fungal Biodiversity Institute, P.O. Box 85167, 3508AD Utrecht, The Netherlands
| |
Collapse
|
3
|
Rahila R, Harish S, Kalpana K, Anand G, Arulsamy M, Kalaivanan R. Antifungal Metabolites of Streptomyces chrestomyceticus STR-2 Inhibits Magnaporthe oryzae, the Incitant of Rice Blast. Curr Microbiol 2023; 80:107. [PMID: 36800015 DOI: 10.1007/s00284-023-03205-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2022] [Accepted: 01/30/2023] [Indexed: 02/18/2023]
Abstract
Rice, a staple food crop worldwide, suffers devastating yield losses as a result of blast disease caused by Magnaporthe oryzae Cav. The adverse effects of chemicals on the environment are rising concerns for sustainable and eco-friendly approaches. The use of antagonistic microbes for the management of rice blast appears to be a sustainable solution to this challenge. Herein, we isolated 20 Streptomyces strains from rice rhizosphere, among which the isolate STR-2 exhibited maximum inhibition of mycelial growth of M. oryzae accounting for 50% reduction over control. The isolate STR-2 was identified as S. chrestomyceticus through 16S rRNA gene sequencing. In vitro tests demonstrated its ability to produce antifungal and bioactive compounds and also synthesize siderophore, IAA, and phosphate-solubilizing agents, thereby promoting plant growth upon inoculation on rice seeds. GC-MS analysis showed the presence of volatiles, antifungal, antimicrobial, and antioxidant compounds with different retention times. The crude antibiotic extract of 0.5% of S. chrestomyceticus STR-2 reduced the mycelial growth of M. oryzae over the control. Application of talc-based formulation of Streptomyces chrestomyceticus STR-2 resulted in the least disease incidence (15.89%) with the highest disease reduction of 65.26% over untreated control under field condition. These findings indicate the potential of S. chrestomyceticus as a potential bio-inoculant against rice blast disease.
Collapse
Affiliation(s)
- R Rahila
- Department of Plant Pathology, Agricultural College and Research Institute, Tamil Nadu Agricultural University, Madurai, Tamil Nadu, 625 104, India
| | - S Harish
- Department of Plant Pathology, Agricultural College and Research Institute, Tamil Nadu Agricultural University, Madurai, Tamil Nadu, 625 104, India.
| | - K Kalpana
- Department of Plant Pathology, Agricultural College and Research Institute, Tamil Nadu Agricultural University, Madurai, Tamil Nadu, 625 104, India
| | - G Anand
- Department of Plant Breeding and Genetics, Agricultural College and Research Institute, Tamil Nadu Agricultural University, Madurai, Tamil Nadu, 625 104, India
| | - M Arulsamy
- Department of Plant Pathology, Agricultural College and Research Institute, Tamil Nadu Agricultural University, Madurai, Tamil Nadu, 625 104, India
| | - R Kalaivanan
- Department of Plant Pathology, Agricultural College and Research Institute, Tamil Nadu Agricultural University, Madurai, Tamil Nadu, 625 104, India
| |
Collapse
|
4
|
Prabu N, Petciappan V, Anand G, Ram S, Kumar A. AB1250 TOFACITINIB IS A SAFE AND EFFECTIVE TREATMENT OPTION FOR JUVENILE IDIOPATHIC ARTHRITIS. Ann Rheum Dis 2022. [DOI: 10.1136/annrheumdis-2022-eular.3173] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
BackgroundThe management of juvenile idiopathic arthritis(JIA) is often constrained by the limited number of oral drugs available. Whether JAK inhibitors would add a much needed therapeutic armamentarium in this regard needs to be explored.ObjectivesTo assess the safety and efficacy of tofacitinib in juvenile idiopathic arthritis (JIA) patient who were prescribed during the period January 2021 to December 2021.MethodsIt’s a retrospective study of JIA patients who were prescribed tofacitinib during the period Jan 21 to Dec 21 with minimum of 3 months’ follow-up after prescribing tofacitinib. The demographics,details of medications,investigations parameters and any adverse events were noted.ResultsThere were a total of 35 patients who were given tofacitinib during this period. Male is to female ratio is 25:10, mean age of 12.91(4.81) yrs., the mean disease duration was 58.6 months. Enthesitis related arthritis(ERA) was the commonest seen in 12, followed by oligo articular in 10, polyarticular in 7 and systemic onset in 6. In the ERA group 10 were HLA B27 +VE, of the oligo articular 6 were ANA +VE, in the polyarticular one was RF +ve. Out of the 35,14 were already on biologicals (tocilizumab and anti TNFs). Tofacitinib was stopped in 8 patients during this period, 5 as they achieved remission, 2 with no response and one because of itching and abdominal pain. There were no documented infections. There was significant reduction in the inflammatory markers (ESR, CRP), leucocyte count and platelet count.Before tofaAfter tofap valueMethotrexate in mg (week) mean(stdev)9.64(1.94)8.88(3.34)0.66Steroid in mg mean (stdev)3(2.35)2.8(1.8)0.91Leucocyte count mean(stdev)11242(1858)7884(1471)0.005Platelet count in lakhsMean(stdev)4.51(0.48)3.37(0.82)0.017ESR mm/1hr57.75(17.25)30.83(11.48)0.009CRP mg/L25.36(10.9)12.36(7.97)0.05ConclusionTofacitinib seems to be a promising drug in the management of JIA with good safety profile and efficacy.References[1] Brunner HI, Schanberg LE, Kimura Y et al. New medications are needed for children with juvenile idiopathic arthritis. Arthritis Rheumatol. 2020; 72: 1945-1951.Disclosure of InterestsNone declared
Collapse
|
5
|
Rajeshkumar KC, Braun U, Groenewald JZ, Lad SS, Ashtekar N, Fatima S, Anand G. Phylogenetic placement and reassessment of Asperisporium pongamiae as Pedrocrousiella pongamiae gen. et comb. nov. ( Mycosphaerellaceae). Fungal Syst Evol 2021; 7:165-176. [PMID: 34124622 PMCID: PMC8166208 DOI: 10.3114/fuse.2021.07.08] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2020] [Accepted: 01/29/2021] [Indexed: 01/22/2023] Open
Abstract
The leaf spot disease of Pongamia pinnata caused by an asperisporium-like asexual morph, which is usually referred to as Asperisporium pongamiae, is quite common during monsoon seasons in India. Phylogenetic analyses, based on LSU and rpb2 sequence data, and blast searches using ITS sequence data, revealed that this ascomycete forms a lineage within Mycosphaerellaceae distant from all other generic lineages. Pedrocrousiella gen. nov., with P. pongamiae comb. nov., based on Fusicladium pongamiae (≡ A. pongamiae), as type species is introduced for this lineage. This species has been considered the asexual morph of Mycosphaerella pongamiae (≡ Stigmatea pongamiae). However, this connection is unproven and was just based on the occasional association of the two taxa in some collections. Several attempts to induce the formation of a sexual morph in culture failed, therefore the putative connection between these morphs could not be confirmed. Asperisporium pongamiae-pinnatae is reduced to synonymy with P. pongamiae. Asperisporium pongamiae-pinnatae was introduced because of the wrong assumption that F. pongamiae had been described on another host, Pongamia globosa. But Fusicladium pongamiae was actually described in India on Pongamia glabra, which is a synonym of P. pinnata, and hence on the same host as Asperisporium pongamiae-pinnatae. Pedrocrousiella pongamiae clusters in a clade containing Distocercospora, Clypeosphaerella, and “Pseudocercospora” nephrolepidicola, a species which is not congeneric with Pseudocercospora. Phylogenetically, Pedrocrousiella is distant from the Asperisporium s. str. clade (type species A. caricae), which is more closely related to Amycosphaerella, Pseudocercosporella, Distomycovellosiella and Nothopassalora. Citation: Rajeshkumar KC, Braun U, Groenewald JZ, Lad SS, Ashtekar N, Fatima S, Anand G (2021). Phylogenetic placement and reassessment of Asperisporium pongamiae as Pedrocrousiella pongamiae gen. et comb. nov. (Mycosphaerellaceae). Fungal Systematics and Evolution7: 165–176. doi: 10.3114/fuse.2021.07.08
Collapse
Affiliation(s)
- K C Rajeshkumar
- National Fungal Culture Collection of India (NFCCI), Biodiversity and Palaeobiology (Fungi) Group, Agharkar Research Institute, Pune, Maharashtra 411 004, India
| | - U Braun
- Martin-Luther-Universität Halle-Wittenberg, Institut für Biologie, Bereich Geobotanik, Herbarium, Neuwerk 21, 06099, Halle (Saale), Germany
| | - J Z Groenewald
- Westerdijk Fungal Biodiversity Institute, Uppsalalaan 8, 3584 CT Utrecht, The Netherlands
| | - S S Lad
- National Fungal Culture Collection of India (NFCCI), Biodiversity and Palaeobiology (Fungi) Group, Agharkar Research Institute, Pune, Maharashtra 411 004, India
| | - N Ashtekar
- National Fungal Culture Collection of India (NFCCI), Biodiversity and Palaeobiology (Fungi) Group, Agharkar Research Institute, Pune, Maharashtra 411 004, India
| | - S Fatima
- National Fungal Culture Collection of India (NFCCI), Biodiversity and Palaeobiology (Fungi) Group, Agharkar Research Institute, Pune, Maharashtra 411 004, India
| | - G Anand
- Department of Botany, University of Delhi, Delhi 110007, India
| |
Collapse
|
6
|
Prabu N, Petciappan V, Anand G, A T, Nijish A. AB0268 LOW DOSE TACROLIMUS IS AN EFFECTIVE ADD ON THERAPY FOR PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS – A SINGLE CENTRE EXPERIENCE. Ann Rheum Dis 2021. [DOI: 10.1136/annrheumdis-2021-eular.2822] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Background:Rheumatoid arthritis (RA) a chronic inflammatory arthritis requiring tight control of disease activity. While traditional DMARDS have been used effectively, there always remains a need for add on drugs in good number of patients. Tacrolimus since its first approval in 2004 had been used widely as monotherapy and in combination with conventional and biological DMARDS. The primary concern was safety followed by the efficacy for patients with active disease.Objectives:The main objective was to ascertain the safety and tolerability of patients who were treated with tacrolimus as an add on therapy over and above the standard care in RA.Methods:A retrospective analysis of patients who were prescribed Tacrolimus from January 2019 to August 2020 was done. Details of patients along with the change in Blood pressure(BP), Serum creatinine, Blood sugar and Clinical disease activity index(CDAI) before and after tacrolimus were analyzed.Results:A total of 245 patients with active Rheumatoid arthritis received the drug. The mean age was 48.58(1.49) years and the disease duration was 5.9(0.56) years. Of 245 patients, 24 patients were lost to follow up,103 patients stopped the drug for various reasons and 118 patients are still continuing the drug. The mean tacrolimus dose was 1.24 + 0.46 mg in the patients who are continuing. The commonest reason for stopping the drug was adverse events (57%) followed by lack of efficacy(29%), low disease activity (8%)and others(7%). There was no significant change in the mean blood pressure, Blood sugars and Creatinine levels in both the stopped and continuing group. However the CDAI and the steroid dosages reduced significantly in the patients who are still on tacrolimus.The lost to follow up group had high disease activity at baseline and also were on higher doses of steroids.PARAMETERSRA – CONTINUING(118)RA STOPPED(103)LOST TO FOLLOWUP(24)BEFORE TACAFTER TACp valueBEFORE TACAFTER TACP valueBEFORE TACSBP mm of hg100.44(9.54)101.06(9.80)0.67103(9.77)104(9.92)0.44127.35(10.05)DBP mm of hg66.30(6.26)67.22(6.37)0.3068.44(6.4)70.43(6.65)0.0782.83(5.05)SUGAR mg76.43(13.73)76.67(11.24)0.9571.86(10.79)76.74(14.1)0.0889.12(9.7)S.CR mg0.55(0.06)0.56(0.09)0.800.66(0.16)0.57(0.06)0.210.74(0.06)STEROID USE mg2.82(0.41)1.65(0.54)<0.0012.12(0.43)2.43(0.54)0.362.86(1.42)CDAI12.28(1.84)7.42(1.49)<0.00112.23(2.03)10.49(2.69)0.0716.62(3.88)Conclusion:Low dose Tacrolimus is an effective add on therapy for patients with high disease activity and did not lead to change in serum creatinine, blood pressure or change in blood sugars in the study subjects.References:[1]Yocum D et al. Safety of tacrolimus in patients with rheumatoid arthritis: long-term experience. Rheumatology 2004; 43:992–999.[2]Shouma Dutta,Yasmeen Ahmad. The efficacy and safety of tacrolimus in rheumatoid arthritis.Therapeutic Advances in Musculoskeletal Disease Ther Adv Musculoskel Dis. 2011; 3(6) 283–291.Disclosure of Interests:None declared
Collapse
|
7
|
Bothou C, Anand G, Li D, Kienitz T, Seejore K, Simeoli C, Ebbehoj A, Ward EG, Paragliola RM, Ferrigno R, Badenhoop K, Bensing S, Oksnes M, Esposito D, Bergthorsdottir R, Drake W, Wahlberg J, Reisch N, Hahner S, Pearce S, Trainer P, Etzrodt-Walter G, Thalmann SP, Sævik ÅB, Husebye E, Isidori AM, Falhammar H, Meyer G, Corsello SM, Pivonello R, Murray R, Bancos I, Quinkler M, Beuschlein F. Current Management and Outcome of Pregnancies in Women With Adrenal Insufficiency: Experience from a Multicenter Survey. J Clin Endocrinol Metab 2020; 105:5840404. [PMID: 32424397 PMCID: PMC7320831 DOI: 10.1210/clinem/dgaa266] [Citation(s) in RCA: 24] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/03/2020] [Accepted: 05/15/2020] [Indexed: 12/31/2022]
Abstract
CONTEXT Appropriate management of adrenal insufficiency (AI) in pregnancy can be challenging due to the rarity of the disease and lack of evidence-based recommendations to guide glucocorticoid and mineralocorticoid dosage adjustment. OBJECTIVE Multicenter survey on current clinical approaches in managing AI during pregnancy. DESIGN Retrospective anonymized data collection from 19 international centers from 2013 to 2019. SETTING AND PATIENTS 128 pregnancies in 113 women with different causes of AI: Addison disease (44%), secondary AI (25%), congenital adrenal hyperplasia (25%), and acquired AI due to bilateral adrenalectomy (6%). RESULTS Hydrocortisone (HC) was the most commonly used glucocorticoid in 83% (97/117) of pregnancies. Glucocorticoid dosage was increased at any time during pregnancy in 73/128 (57%) of cases. In these cases, the difference in the daily dose of HC equivalent between baseline and the third trimester was 8.6 ± 5.4 (range 1-30) mg. Fludrocortisone dosage was increased in fewer cases (7/54 during the first trimester, 9/64 during the second trimester, and 9/62 cases during the third trimester). Overall, an adrenal crisis was reported in 9/128 (7%) pregnancies. Cesarean section was the most frequent mode of delivery at 58% (69/118). Fetal complications were reported in 3/120 (3%) and minor maternal complications in 15/120 (13%) pregnancies without fatal outcomes. CONCLUSIONS This survey confirms good maternal and fetal outcome in women with AI managed in specialized endocrine centers. An emphasis on careful endocrine follow-up and repeated patient education is likely to have reduced the risk of adrenal crisis and resulted in positive outcomes.
Collapse
Affiliation(s)
- Christina Bothou
- Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, Universitätsspital Zürich, Zürich, Switzerland
| | - Gurpreet Anand
- Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, Universitätsspital Zürich, Zürich, Switzerland
| | - Dingfeng Li
- Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, Minnesota
| | - Tina Kienitz
- Endocrinology in Charlottenburg, Berlin, Germany
| | - Khyatisha Seejore
- Department of Endocrinology, Leeds Teaching Hospitals NHS Trust, St James’s University Hospital, Leeds, UK
| | - Chiara Simeoli
- Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Università Federico II di Napoli, Naples, Italy
| | - Andreas Ebbehoj
- Department of Clinical Medicine, Department of Endocrinology and Diabetes, Aarhus University, Aarhus, Denmark
| | - Emma G Ward
- Department of Endocrinology, Leeds Teaching Hospitals NHS Trust, St James’s University Hospital, Leeds, UK
| | - Rosa Maria Paragliola
- Unit of Endocrinology, Università Cattolica del Sacro Cuore – Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
| | - Rosario Ferrigno
- Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Università Federico II di Napoli, Naples, Italy
| | - Klaus Badenhoop
- Department of Internal Medicine I, Division of Endocrinology, Diabetes and Metabolism, University Hospital, Frankfurt, Germany
| | - Sophie Bensing
- Department of Molecular Medicine and Surgery, Karolinska Institutet and Department of Endocrinology, Inflammation and Infection Theme, Karolinska University Hospital, Stockholm, Sweden
| | - Marianne Oksnes
- Endocrinology in Charlottenburg, Berlin, Germany
- Department of Clinical Science and K.G. Jebsen Center for Autoimmune Disorders, University of Bergen, Jonas Liesvei, Bergen, Norway
| | - Daniela Esposito
- Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
- Department of Endocrinology, Sahlgrenska, University Hospital, Gothenburg, Sweden
| | - Ragnhildur Bergthorsdottir
- Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
- Department of Endocrinology, Sahlgrenska, University Hospital, Gothenburg, Sweden
| | - William Drake
- Department of Endocrinology, St Bartholomew’s Hospital, London, UK
| | - Jeanette Wahlberg
- Department of Endocrinology, and Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden
| | - Nicole Reisch
- Department of Endocrinology, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany
| | - Stefanie Hahner
- Department of Internal Medicine I, Endocrinology and Diabetes Unit, University Hospital of Würzburg, University of Würzburg, Germany
| | - Simon Pearce
- Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK
| | - Peter Trainer
- The Christie NHS Foundation, MAHSC, Wilmslow Road, Manchester, UK
| | | | | | - Åse B Sævik
- Department of Clinical Science and K.G. Jebsen Center for Autoimmune Disorders, University of Bergen, Jonas Liesvei, Bergen, Norway
| | - Eystein Husebye
- Department of Clinical Science and K.G. Jebsen Center for Autoimmune Disorders, University of Bergen, Jonas Liesvei, Bergen, Norway
| | - Andrea M Isidori
- Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy
| | - Henrik Falhammar
- Department of Molecular Medicine and Surgery, Karolinska Institutet and Department of Endocrinology, Inflammation and Infection Theme, Karolinska University Hospital, Stockholm, Sweden
| | - Gesine Meyer
- Department of Internal Medicine I, Division of Endocrinology, Diabetes and Metabolism, University Hospital, Frankfurt, Germany
| | - Salvatore M Corsello
- Unit of Endocrinology, Università Cattolica del Sacro Cuore – Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
| | - Rosario Pivonello
- Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Università Federico II di Napoli, Naples, Italy
| | - Robert Murray
- Department of Endocrinology, Leeds Teaching Hospitals NHS Trust, St James’s University Hospital, Leeds, UK
| | - Irina Bancos
- Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, Minnesota
| | | | - Felix Beuschlein
- Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, Universitätsspital Zürich, Zürich, Switzerland
- Department of Endocrinology, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany
- Correspondence and Reprint Requests: Prof. Felix Beuschlein, MD, Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, Universitätsspital Zürich, Raemistrasse 100, CH-8091 Zürich, Switzerland. E-mail:
| |
Collapse
|
8
|
Evans R, Taylor S, Kalasthry J, Sakai N, Miles A, Aboagye A, Agoramoorthy L, Ahmed S, Amadi A, Anand G, Atkin G, Austria A, Ball S, Bazari F, Beable R, Beare S, Beedham H, Beeston T, Bharwani N, Bhatnagar G, Bhowmik A, Blakeway L, Blunt D, Boavida P, Boisfer D, Breen D, Bridgewater J, Burke S, Butawan R, Campbell Y, Chang E, Chao D, Chukundah S, Clarke C, Collins B, Collins C, Conteh V, Couture J, Crosbie J, Curtis H, Daniel A, Davis L, Desai K, Duggan M, Ellis S, Elton C, Engledow A, Everitt C, Ferdous S, Frow A, Furneaux M, Gibbons N, Glynne-Jones R, Gogbashian A, Goh V, Gourtsoyianni S, Green A, Green L, Green L, Groves A, Guthrie A, Hadley E, Halligan S, Hameeduddin A, Hanid G, Hans S, Hans B, Higginson A, Honeyfield L, Hughes H, Hughes J, Hurl L, Isaac E, Jackson M, Jalloh A, Janes S, Jannapureddy R, Jayme A, Johnson A, Johnson E, Julka P, Kalasthry J, Karapanagiotou E, Karp S, Kay C, Kellaway J, Khan S, Koh D, Light T, Limbu P, Lock S, Locke I, Loke T, Lowe A, Lucas N, Maheswaran S, Mallett S, Marwood E, McGowan J, Mckirdy F, Mills-Baldock T, Moon T, Morgan V, Morris S, Morton A, Nasseri S, Navani N, Nichols P, Norman C, Ntala E, Nunes A, Obichere A, O'Donohue J, Olaleye I, Oliver A, Onajobi A, O'Shaughnessy T, Padhani A, Pardoe H, Partridge W, Patel U, Perry K, Piga W, Prezzi D, Prior K, Punwani S, Pyers J, Rafiee H, Rahman F, Rajanpandian I, Ramesh S, Raouf S, Reczko K, Reinhardt A, Robinson D, Rockall A, Russell P, Sargus K, Scurr E, Shahabuddin K, Sharp A, Shepherd B, Shiu K, Sidhu H, Simcock I, Simeon C, Smith A, Smith D, Snell D, Spence J, Srirajaskanthan R, Stachini V, Stegner S, Stirling J, Strickland N, Tarver K, Teague J, Thaha M, Train M, Tulmuntaha S, Tunariu N, van Ree K, Verjee A, Wanstall C, Weir S, Wijeyekoon S, Wilson J, Wilson S, Win T, Woodrow L, Yu D. Patient deprivation and perceived scan burden negatively impact the quality of whole-body MRI. Clin Radiol 2020; 75:308-315. [PMID: 31836179 DOI: 10.1016/j.crad.2019.10.019] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2019] [Accepted: 10/30/2019] [Indexed: 01/26/2023]
Abstract
AIM To evaluate the association between the image quality of cancer staging whole-body magnetic resonance imaging (WB-MRI) and patient demographics, distress, and perceived scan burden. MATERIALS AND METHODS A sample of patients recruited prospectively to multicentre trials comparing WB-MRI with standard scans for staging lung and colorectal cancer were invited to complete two questionnaires. The baseline questionnaire, administered at recruitment, collated data on demographics, distress and co-morbidity. The follow-up questionnaire, completed after staging investigations, measured perceived WB-MRI scan burden (scored 1 low to 7 high). WB-MRI anatomical coverage, and technical quality was graded by a radiographic technician and grading combined to categorise the scan as "optimal", "sub-optimal" or "degraded". A radiologist categorised 30 scans to test interobserver agreement. Data were analysed using the chi-square, Fisher's exact, t-tests, and multinomial regression. RESULTS One hundred and fourteen patients were included in the study (53 lung, 61 colorectal; average age 65.3 years, SD=11.8; 66 men [57.9%]). Overall, 45.6% (n=52), scans were classified as "optimal" quality, 39.5% (n=45) "sub-optimal", and 14.9% (n=17) as "degraded". In adjusted analyses, greater deprivation level and higher patient-reported scan burden were both associated with a higher likelihood of having a sub-optimal versus an optimal scan (odds ratio [OR]: 4.465, 95% confidence interval [CI]: 1.454 to 13.709, p=0.009; OR: 1.987, CI: 1.153 to 3.425, p=0.013, respectively). None of the variables predicted the likelihood of having a degraded scan. CONCLUSIONS Deprivation and patients' perceived experience of the WB-MRI are related to image quality. Tailored protocols and individualised patient management before and during WB-MRI may improve image quality.
Collapse
|
9
|
Yan H, Jiang Y, Luong M, Naban N, Kane C, Conibear J, Papadatos-Pastos D, Ahmad T, Chao D, Asghar U, Anand G. Delayed onset immune related adverse effects (IRAEs) of pembrolizumab in non-small cell lung cancer. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz260.032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
10
|
Greenberg A, Yan H, Anand G, Raja F. A Closed-loop Audit of 5 versus 10 Days of Primary GCSF Prophylaxis to Reduce the Incidence of Febrile Neutropenia in Early Breast Cancer Treatment. Clin Oncol (R Coll Radiol) 2019. [DOI: 10.1016/j.clon.2019.03.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
11
|
Bhalla N, Palanisamy M, Anand G, Saravanan C, Thangaraj T, Abhishek P. EP-1810 Comparison of absorbed dose between medium and water on Monte Carlo algorithm for VMAT plan. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)32230-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
12
|
Anand G, Bink A, Beuschlein F, Schmid C. Dopamine agonist-responsive Cushing’s disease. BMJ Case Rep 2019; 12:12/2/bcr-2018-228045. [DOI: 10.1136/bcr-2018-228045] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Abstract
A 47-year-old Caucasian man was referred to our clinic with a severe clinical and biochemical phenotype of endogenous hypercortisolism for further evaluation and treatment. In addition to confirming adrenocorticotropic hormone (ACTH)-dependent Cushing’s syndrome, we found left temporal hemianopsia, massively increased prolactin, increased growth hormone/insulin-like growth factor 1 values, hypogonadotropic hypogonadism and central hypothyroidism. As the cause of these abnormalities we revealed an invasive macroadenoma of the pituitary secreting ACTH, prolactin and growth hormone, resulting not only in a clinically predominant picture of Cushing’s syndrome but also causing hypogonadotropic hypogonadism and central hypothyroidism. The patient responded surprisingly well to dopamine agonist treatment leading not only to normalisation of prolactin levels but also to clinical and biochemical remission of Cushing’s syndrome. Tumour size decreased successively in follow-up MRI scans. Despite lacking immunohistochemical analysis of tumour tissue, we assume plurihormonal secretion of ACTH, prolactin and growth hormone from pituitary macroadenoma, which fortunately responded well to dopamine agonist treatment.
Collapse
|
13
|
Robinson SD, Lai C, Hotton G, Anand G. Life threatening pembrolizumabinduced myositis in a patient treated for advanced adenocarcinoma of the lung. Acute Med 2019; 18:197-199. [PMID: 31536059] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
The advent of immunotherapy in oncology has led to the emergence of a new spectrum of adverse effects. A number of these have the potential to contribute to life-threatening outcomes; and therefore require prompt identification and aggressive treatment to optimise management. In this report, we describe a case of pembrolizumab-induced CTCAE (common toxicity criteria for adverse events) grade 4 myositis in a non-small cell lung cancer patient.
Collapse
Affiliation(s)
- S D Robinson
- Department of Oncology, North Middlesex University Hospital, London
| | - C Lai
- Department of Oncology, North Middlesex University Hospital, London
| | - G Hotton
- Department of Neurology, North Middlesex University Hospital, London
| | - G Anand
- Department of Oncology, North Middlesex University Hospital, London
| |
Collapse
|
14
|
Abstract
Endocrine active adrenal tumors are associated with a relevant risk of complications during surgery, either due to direct hemodynamic effects of the hormone excess or due to hormone related comorbidities. Over the last decades, careful preoperative evaluation and improved peri-interventional medical management of affected patients has resulted in a significant reduction of perioperative complications. In addition, improvement in anesthesia and surgical techniques with the feasibility of laparoscopic adrenalectomy have contributed to reduce morbidity. Nevertheless, there are still several challenges to be considered in the perioperative care of these patients. Due to the rarity of functionally active adrenal tumors, there are no prospective data available to guide clinical management. Accordingly, most recommendations are based on retrospective data analysis, expert opinion or carry weak evidence based on small series or case reports. The aim of this review is to summarize the current knowledge and to suggest practical approaches to reduce perioperative complications in endocrine active adrenal tumors. This review exclusively deals with data from adult patients with functionally active adrenal tumors.
Collapse
Affiliation(s)
- Florentine Schreiner
- Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, Universitätsspital Zürich, Zürich, Switzerland
| | - Gurpreet Anand
- Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, Universitätsspital Zürich, Zürich, Switzerland
| | - Felix Beuschlein
- Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, Universitätsspital Zürich, Zürich, Switzerland.,Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany
| |
Collapse
|
15
|
Anand G, Beuschlein F. MANAGEMENT OF ENDOCRINE DISEASE: Fertility, pregnancy and lactation in women with adrenal insufficiency. Eur J Endocrinol 2018; 178:R45-R53. [PMID: 29191934 DOI: 10.1530/eje-17-0975] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/20/2017] [Revised: 11/30/2017] [Accepted: 11/30/2017] [Indexed: 12/21/2022]
Abstract
With the introduction of hormonal substitution therapy in the 1950s, adrenal insufficiency (AI) has been turned into a manageable disease in pregnant women. In fact, in the light of glucocorticoid replacement therapy and improved obstetric care, it is realistic to expect good maternal and fetal outcomes in patients with AI. However, there are still a number of challenges such as establishing the diagnosis of AI in pregnant women and optimizing the treatment of AI and related comorbidities prior to as well as during pregnancy. Clinical and biochemical diagnoses of a new-onset AI may be challenging because of overlapping symptoms of normal pregnancy as well as pregnancy-induced changes in cortisol values. Physiological changes occurring during pregnancy should be taken into account while adjusting the substitution therapy. The high proportion of reported adrenal crisis in pregnant women with AI highlights persistent problems in this particular clinical situation. Due to the rarity of the disease, there is no prospective data-guiding management of pregnancy in patients with known AI. The aim of this review is to summarize the maternal and fetal outcomes based on recently published case reports in patients with AI and to suggest a practical approach to diagnose and manage AI in pregnancy.
Collapse
Affiliation(s)
- Gurpreet Anand
- Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, UniversitätsSpital Zürich, Zürich, Switzerland
| | - Felix Beuschlein
- Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, UniversitätsSpital Zürich, Zürich, Switzerland
- Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany
| |
Collapse
|
16
|
Anand G, Beuschlein F, Schmid C. [Not Available]. Praxis (Bern 1994) 2017; 106:1033-1038. [PMID: 28927363 DOI: 10.1024/1661-8157/a002783] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
Zusammenfassung. Nebenniereninzidentalome sind Raumforderungen der Nebenniere, welche in einer Bildgebung der Bauchregion unerwartet gefunden werden, ohne dass vorher eine zielführende Klinik und die Labordiagnostik einer Nebennierenerkrankung vorliegen und zur Bildgebung Anlass gegeben hätten. Das Inzidentalom ist keine eigenständige Diagnose. Es sollte grundsätzlich (bereits bei der Erstdiagnose) die Dignität der Raumforderung (benigne versus maligne) festgelegt und eine allfällig relevante Hormonproduktion ausgeschlossen oder nachgewiesen werden. Bei hormoninaktiven Tumoren sowie bei morphologisch eindeutig benignen Tumoren (Dichte <10 Hounsfield-Einheiten, Grösse <4 cm) kann auf eine weitere Nachsorge verzichtet werden, falls auch im Verlauf keine klinischen Verdachtsmomente hinzukommen. Bei unklaren und komplexen Fällen sollte die geeignete Nachsorge in einem interdisziplinären Tumorboard besprochen werden. Wenn die Indikation für eine Operation gestellt wird (z.B. hormonaktive Tumoren, maligne Raumforderung <6 cm ohne Hinweise auf Lokalinvasion), kann diese in einem spezialisierten Zentrum meist laparoskopisch (inkl. retroperitoneoskopisch) erfolgen.
Collapse
Affiliation(s)
- Gurpreet Anand
- 1 Klinik für Endokrinologie, Diabetologie und klinische Ernährung, Universitätsspital Zürich
| | - Felix Beuschlein
- 1 Klinik für Endokrinologie, Diabetologie und klinische Ernährung, Universitätsspital Zürich
- 2 Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, München, Deutschland
| | - Christoph Schmid
- 1 Klinik für Endokrinologie, Diabetologie und klinische Ernährung, Universitätsspital Zürich
| |
Collapse
|
17
|
Yadav S, Maurya SK, Anand G, Dwivedi R, Yadav D. Purification, characterization and retting of Crotolaria juncea fibres by an alkaline pectin lyase from Fusarium oxysporum MTCC 1755. 3 Biotech 2017; 7:136. [PMID: 28593518 DOI: 10.1007/s13205-017-0750-5] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2016] [Accepted: 01/30/2017] [Indexed: 11/30/2022] Open
Abstract
Using solid-state fermentation, production of an industrially important pectin lyase from a fungal strain Fusarium oxysporum MTCC 1755 was attempted, which was further subjected to purification and characterization. The enzyme was purified by three steps, namely ammonium sulfate fractionation, cation-exchange chromatography on CM cellulose followed by gel filtration chromatography using Sephadex G-100 column. A 16-fold purification with 31.2% yield and 3.2 U/mg specific activity was achieved. The optimum pH of the purified enzyme was 9.0 and stability ranged from pH 5.0-7.0 for 24 h. Optimum temperature of purified enzyme was found to be 40 °C while temperature stability ranged from 10 to 50 °C for 30 min. The K m and k cat of the enzyme was 1.75 mg/ml and 83.3 s-1, respectively. The purified enzyme was found to be highly stimulated by Ca2+ ions while sugars like mannitol and sorbitol, and salts like NaCl and CaCl2 enhanced the thermostability. The purified pectin lyase was found suitable for retting of Crotolaria juncea fiber.
Collapse
Affiliation(s)
- S Yadav
- Department of Biotechnology, DDU Gorakhpur University, Gorakhpur, 273009, India.
| | - S K Maurya
- Department of Biotechnology, DDU Gorakhpur University, Gorakhpur, 273009, India
| | - G Anand
- Department of Biotechnology, DDU Gorakhpur University, Gorakhpur, 273009, India
| | - R Dwivedi
- Department of Biotechnology, DDU Gorakhpur University, Gorakhpur, 273009, India
| | - D Yadav
- Department of Biotechnology, DDU Gorakhpur University, Gorakhpur, 273009, India
| |
Collapse
|
18
|
Anand G, Alagumurthi N, Elansezhian R, Venkateshwaran N. Ni-P Coated Glass Fiber/Al₂O₃ Nanowire Reinforced Vinyl Ester Composite. pk 2017. [DOI: 10.7317/pk.2017.41.3.443] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
19
|
Anand G, Christense RN. Theoretical and Experimental Analysis of the Bistable Convection Loop for Liquid-Metal-Cooled Reactor Emergency Core Cooling. NUCL TECHNOL 2017. [DOI: 10.13182/nt92-a34725] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- G. Anand
- The Ohio State University Robinson Laboratory, 206 West 18th Avenue, Columbus, Ohio 43210
| | - R. N. Christense
- The Ohio State University Robinson Laboratory, 206 West 18th Avenue, Columbus, Ohio 43210
| |
Collapse
|
20
|
Abstract
Iron deficiency is common and can be effectively treated with parenteral iron infusion. We report a case of an iron-deficient and vitamin D-deficient woman who developed severe symptomatic hypophosphataemia following intravenous ferric carboxymaltose administration. We stress the need of increased awareness of this potential complication among physicians. Patients should be informed of this complication and instructed to report for follow-up if they experience new musculoskeletal symptoms or worsening of tiredness. As severe hypophosphataemia is usually symptomatic, we recommend screening symptomatic patients for this complication. Recognising and treating the possible exacerbating factors, especially vitamin D deficiency, might be a simple measure to mitigate this complication.
Collapse
Affiliation(s)
- Gurpreet Anand
- Division of Endocrinology, University Hospital Zürich, Zürich, Switzerland
| | - Christoph Schmid
- Division of Endocrinology, University Hospital Zürich, Zürich, Switzerland
| |
Collapse
|
21
|
Anand G, Beuschlein F, Schmid C. [Not Available]. Praxis (Bern 1994) 2017; 106:1129. [PMID: 28976255 DOI: 10.1024/1661-8157/a002784] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Affiliation(s)
- Gurpreet Anand
- 1 Klinik für Endokrinologie, Diabetologie und klinische Ernährung, Universitätsspital Zürich
| | - Felix Beuschlein
- 1 Klinik für Endokrinologie, Diabetologie und klinische Ernährung, Universitätsspital Zürich
- 2 Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, München, Deutschland
| | - Christoph Schmid
- 1 Klinik für Endokrinologie, Diabetologie und klinische Ernährung, Universitätsspital Zürich
| |
Collapse
|
22
|
Anand G, Collett-White F, Orsini A, Thomas S, Jayapal S, Trump N, Zaiwalla Z, Jayawant S. Autosomal dominant SCN8A mutation with an unusually mild phenotype. Eur J Paediatr Neurol 2016; 20:761-5. [PMID: 27210545 DOI: 10.1016/j.ejpn.2016.04.015] [Citation(s) in RCA: 35] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/04/2016] [Revised: 04/19/2016] [Accepted: 04/25/2016] [Indexed: 11/19/2022]
Abstract
BACKGROUND Mutations in SCN8A, coding for the voltage-gated sodium channel Nav 1.6, have been described in relation to infantile onset epilepsy with developmental delay and cognitive impairment, in particular early onset epileptic encephalopathy (EIEE) type 13. CASE REPORT Here we report an infant and his father with early onset focal epileptic seizures but without cognitive or neurological impairment in whom next generation sequence analysis identified a heterozygous mutation (c.5630A > G, p. (Asn1877Ser)) in the SCN8A gene. This mutation, confirmed by Sanger sequence analysis, affects a highly conserved amino acid and in silico tools predicts that it may be pathogenic. The reported infant has a normal developmental profile at 16-month follow-up. His father also had normal development and has no cognitive impairment at 42 years. This is the second known SCN8A mutation associated with a phenotype of benign familial infantile epilepsy. Good seizure control was achieved in our patients with sodium channel blockers. CONCLUSION Based on our proband and a recently described group of families with benign familial infantile epilepsy and SCN8A variant we suggest expanding testing to patients with infantile epilepsy and no cognitive impairment. In addition, the same SCN8A variant (c.5630A > G, p. (Asn1877Ser)) is also found in patients with epilepsy and developmental delay highlighting the phenotypic variability and the possible role of other protective genetic factors.
Collapse
Affiliation(s)
- G Anand
- Department of Paediatric Neurology, Oxford Children's Hospital, Oxford, UK.
| | - F Collett-White
- Department of Paediatric Neurology, Oxford Children's Hospital, Oxford, UK
| | - A Orsini
- Department of Paediatric Neurology, Oxford Children's Hospital, Oxford, UK
| | - S Thomas
- Department of Paediatric Neurology, Oxford Children's Hospital, Oxford, UK
| | - S Jayapal
- Royal Berkshire Hospital, Reading, UK
| | - N Trump
- North East Thames Regional Genetics Service, Great Ormond Street Hospital, London, UK
| | - Z Zaiwalla
- Department of Paediatric Neurology, Oxford Children's Hospital, Oxford, UK
| | - S Jayawant
- Department of Paediatric Neurology, Oxford Children's Hospital, Oxford, UK
| |
Collapse
|
23
|
Ranger A, Buckley H, Bhuva N, Koay J, Anand G. Palliative Whole Brain Radiotherapy in Primary Lung Cancer – Are We Doing Too Much? Clin Oncol (R Coll Radiol) 2014. [DOI: 10.1016/j.clon.2014.04.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
24
|
Yadav S, Dubey AK, Anand G, Yadav D. Purification and characterization of pectin lyase secreted by Aspergillus flavus MTCC 10938. ACTA ACUST UNITED AC 2014; 49:396-401. [PMID: 24455866 DOI: 10.7868/s0555109913040156] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
An indigenously isolated fungal strain Aspergillus flavus MTCC 10938 was subjected to pectin lyase (PNL) production under submerged fermentation conditions. The enzyme was purified to homogeneity from the culture filtrate of the fungus involving concentration by ultrafiltration, anion exchange chromatography on DEAE cellulose and gel filtration chromatography on Sephadex G-100. The purified PNL gave a single protein band in SDS-PAGE analysis with a relative molecular mass corresponding to 50 kDa. Using citrus pectin as the substrate the K(m) and k(cat) values of the enzyme lyase were obtained as 1.7 mg/mL and 66 s(-1), respectively. The optimum pH of the purified PNL from A. flavus MTCC 10938 was 8.0 and up to 90% of its activity retained in the pH range from 3.0 to 11.0 after 24 h incubation. The optimum temperature of the purified enzyme was revealed at 55 degrees C and it was completely stable up to 40 degrees C when exposed for 30 min. The purified A. flavus MTCC 10938 PNL showed efficient retting of Crotalaria juncea fibres.
Collapse
Affiliation(s)
- S Yadav
- Department of Biotechnology, D.D.U. Gorakhpur University, Gorakhpur 273009, India.
| | - A K Dubey
- Department of Biotechnology, D.D.U. Gorakhpur University, Gorakhpur 273009, India
| | - G Anand
- Department of Biotechnology, D.D.U. Gorakhpur University, Gorakhpur 273009, India
| | - D Yadav
- Department of Biotechnology, D.D.U. Gorakhpur University, Gorakhpur 273009, India
| |
Collapse
|
25
|
Kishor Kumar J, Gunasekaran S, Loganathan S, Anand G, Kumaresan S. The molecular structure, geometry, stability, thermal and fundamental modes of vibration of glycine dimer by DFT methods. Spectrochim Acta A Mol Biomol Spectrosc 2013; 115:730-737. [PMID: 23892114 DOI: 10.1016/j.saa.2013.06.097] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/17/2013] [Revised: 06/25/2013] [Accepted: 06/27/2013] [Indexed: 06/02/2023]
Abstract
Glycine is an important amino acid for building up protein synthesis. Single crystal of glycine dimer was grown from aqueous solution by slow evaporation method. Powder X-ray diffraction analysis confirms the crystalline nature of grown crystal. It is interesting to study the molecular structure of a dimer, having well-defined channels formed through amphoterism bonding between CO⋯H bonds with split-valence basis sets, and the conformer is mirror symmetrical, in which the protonated organic cation plays a significant role to have a dimer pattern. Amphiprotic molecules, like dimeric glycine which can either donate or accept a proton (H(+)) from each other. Optical absorption study reveals that the transparency of the crystal in the entire visible region and the cutoff wavelength was found to be 235nm. Powder SHG test and thermogravimetric analysis shows glycine dimer crystal is optically active and thermally stable. The molecular structure, geometry, stability and theoretical vibrational spectra were calculated for glycine as a monomer and as a dimer linked by the amphoterism hydrogen bonding. The theoretical studies were performed using the B3LYP density functional method with the 6-311G (d,p) basis set. The detailed interpretation of the vibrational spectra has been made on the basis of normal coordinate analysis.
Collapse
Affiliation(s)
- J Kishor Kumar
- PG & Research Department of Physics, Arignar Anna Government Arts College, Cheyyar 604 410, Tamilnadu, India
| | | | | | | | | |
Collapse
|
26
|
Yadav S, Dubey AK, Anand G, Yadav D. Purification and characterization of pectin lyase secreted by Aspergillus flavus MTCC 10938. APPL BIOCHEM MICRO+ 2013. [DOI: 10.1134/s0003683813040145] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
27
|
Anand G, Kodali R, Santosh Kumar B. Development of analytic network process for the selection of material handling systems in the design of flexible manufacturing systems (FMS). J of Advances in Mgmt Research 2011. [DOI: 10.1108/09727981111129336] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
28
|
Anand G, Keaney K, Anthony M, Quaghebeur G. Multiple facets of PHACE(S). Case Reports 2010; 2010:bcr12.2009.2522. [DOI: 10.1136/bcr.12.2009.2522] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
|
29
|
|
30
|
|
31
|
Anand G, Kodali R. Application of value stream mapping and simulation for the design of lean manufacturing systems: a case study. ACTA ACUST UNITED AC 2009. [DOI: 10.1504/ijspm.2009.031094] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
32
|
|
33
|
Abstract
PurposeIn recent years, many manufacturing companies are attempting to implement lean manufacturing systems (LMS) as an effective manufacturing strategy to survive in a highly competitive market. Such a process of selecting a suitable manufacturing system is highly complex and strategic in nature. The paper aims to how companies make a strategic decision of selecting LMS as part of their manufacturing strategy, and on what basis such strategic decisions are made by the managers.Design/methodology/approachA case study of a small‐ and medium‐sized enterprise is presented, in which the managers are contemplating on implementing either computer integrated manufacturing systems (CIMS) or LMS. To supplement the decision‐making process, a multi‐criteria decision making (MCDM) model, namely, the preference ranking organisation method for enrichment evaluations (PROMETHEE) is used to analyse how it will impact the stakeholders of the organisation, and the benefits gained.FindingsAn extensive analysis of PROMETHEE model revealed that LMS was the best for the given circumstances of the case.Research limitations/implicationsThe same problem can be extended by incorporating the constraints (such as financial, technical, social) of the organisation by utilising an extended version of PROMETHEE called the PROMETHEE V. Since, a single case study approach has been utilised, the findings cannot be generalized for any other industry.Practical limitations/implicationsThe methodology of PROMETHEE and its algorithm has been demonstrated in a detailed way and it is believed that it will be useful for managers to apply such MCDM tools to supplement their decision‐making efforts.Originality/valueAccording to the authors’ knowledge there is no paper in the literature, which discusses the application of PROMETHEE in making a strategic decision of implementing LMS as a part of an organisation's manufacturing strategy.
Collapse
|
34
|
|
35
|
|
36
|
Tamilselvi D, Anand G, Swarup S. A geminivirus AYVV-derived shuttle vector for tobacco BY2 cells. Plant Cell Rep 2004; 23:81-90. [PMID: 15069580 DOI: 10.1007/s00299-004-0792-0] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/21/2004] [Revised: 03/01/2004] [Accepted: 03/03/2004] [Indexed: 05/24/2023]
Abstract
We have developed a plant- Escherichia coli pASV shuttle vector from the essential elements of the Ageratum yellow vein virus (AYVV). The geminivirus vector contains the AYVV genome with the coat-protein deletion, the E. coli vector backbone of pUC19, a unique cloning site and gene expression cassettes for plant selection and reporter gene activity. The replication of pASV vectors was compared in Nicotiana benthamiana and N. tabacum BY2 cells, and the latter were found to be suitable for long-term maintenance of the vectors in culture. The vector DNA was detected at regular intervals by PCR, beta-glucuronidase expression analysis and plasmid rescue during a 4-month culture period. A novel methylation-based PCR assay was carried out to show de novo replication for pASV-derived vectors in 2-month-old tobacco BY2 cell lines. This is the first report of the extrachromosomal replication of monopartite begomovirus with stability and foreign gene expression in long-term cell cultures.
Collapse
MESH Headings
- Cell Culture Techniques/methods
- Cells, Cultured/cytology
- Cells, Cultured/metabolism
- Cells, Cultured/virology
- Geminiviridae/genetics
- Gene Expression Regulation, Plant/genetics
- Gene Expression Regulation, Viral/genetics
- Genes, Reporter/genetics
- Genetic Engineering/methods
- Genetic Vectors/genetics
- Glucuronidase/genetics
- Plants, Genetically Modified/genetics
- Plants, Genetically Modified/growth & development
- Plants, Genetically Modified/virology
- Plasmids/genetics
- Polymerase Chain Reaction/methods
- Nicotiana/genetics
- Nicotiana/growth & development
- Nicotiana/virology
- Transformation, Genetic/genetics
Collapse
Affiliation(s)
- D Tamilselvi
- Department of Biological Sciences, National University of Singapore, 117 543, Singapore
| | | | | |
Collapse
|
37
|
Taylor SS, Yang J, Wu J, Haste NM, Radzio-Andzelm E, Anand G. PKA: a portrait of protein kinase dynamics. Biochim Biophys Acta 2004; 1697:259-69. [PMID: 15023366 DOI: 10.1016/j.bbapap.2003.11.029] [Citation(s) in RCA: 249] [Impact Index Per Article: 12.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/06/2003] [Accepted: 11/12/2003] [Indexed: 11/21/2022]
Abstract
Protein kinases play a critical role in the integration of signaling networks in eukaryotic cells. cAMP-dependent protein kinase (PKA) serves as a prototype for this large and highly diverse enzyme family. The catalytic subunit of PKA provides the best example of how a protein kinase recognizes its substrates, as well as inhibitors, and also show how the enzyme moves through the steps of catalysis. Many of the relevant conformational states associated with the catalytic cycle which have been captured in a crystal lattice are summarized here. From these structures, we can begin to appreciate the molecular events of catalysis as well as the intricate orchestration of critical residues in the catalytic subunit that contribute to catalysis. The entire molecule participates. To fully understand signaling by PKA, however, requires an understanding of a large set of related proteins, not just the catalytic subunit. This includes the regulatory subunits that serve as receptors for cAMP and the A kinase anchoring proteins (AKAPs) that serve as scaffolds for PKA. The AKAPs localize PKA to specific sites in the cell by docking to the N-terminus of the regulatory subunits, thus creating microenvironments for PKA signaling. To fully appreciate the diversity and integration of these molecules, one needs not only high-resolution structures but also an appreciation of how these molecules behave in solution. Thus, in addition to obtaining high-resolution structures by X-ray crystallography and NMR, we have used fluorescent tools and also hydrogen/deuterium exchange coupled with mass spectrometry to probe the dynamic properties of these proteins and how they interact with one another. The molecular features of these molecules are described. Finally, we describe a new recombinantly expressed PKA reporter that allows us to monitor PKA activity in living cells.
Collapse
Affiliation(s)
- S S Taylor
- Howard Hughes Medical Institute, Bethesda, MD, USA
| | | | | | | | | | | |
Collapse
|
38
|
Harris VK, Richard VS, Mathai E, Sitaram U, Kumar KV, Cherian AM, Amelia SM, Anand G. A study on clinical profile of falciparum malaria in a tertiary care hospital in south India. Indian J Malariol 2001; 38:19-24. [PMID: 11963816] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/24/2023]
Abstract
Malaria continues to be a major problem in tropical countries. To study the clinical features and complications of malaria in a tertiary care hospital in south India, records of 183 patients were analysed. Among 86 patients with P. falciparum and mixed infection, 24 (28 per cent) had cerebral malaria and 32 (37 per cent) had hyperbilirubinemia. Twenty-three out of 32 (72 per cent) patients with jaundice had direct hyperbilirubinemia and elevated liver enzymes suggesting hepatocellular damage. Mortality of the order of 10 per cent was seen only in P. falciparum malaria. High incidence of hepatic involvement and hepatorenal failure were the unusual features observed in the study.
Collapse
Affiliation(s)
- V K Harris
- Department of Clinical Pathology, Christian Medical College and Hospital, Vellore-632 004, India
| | | | | | | | | | | | | | | |
Collapse
|
39
|
Gupta K, Anand G, Yin X, Grove L, Prochownik EV. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc. Oncogene 1998; 16:1149-59. [PMID: 9528857 DOI: 10.1038/sj.onc.1201634] [Citation(s) in RCA: 24] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
C-myc, a member of the basic helix-loop-helix-leucine zipper (bHLH-ZIP) protein family activates target genes in heterodimeric association with another bHLH-ZIP protein, Max. Max readily homodimerizes, competes with C-myc-Max heterodimers, and represses transcription. Four additional bHLH-ZIP proteins, Mad1, Mxi1, Mad3 and Mad4, heterodimerize with Max and also repress transcription of c-myc-responsive genes. We employed a yeast two-hybid approach to identify proteins which interact with Mxi. We identified a novel ZIP-containing protein, Mmip1 (Mad member-interacting protein 1) that strongly dimerizes with all four Mad members, but not with c-myc, Max, or with unrelated HLH proteins. The Mmip1-Mxi association is mediated by the ZIP domain of each polypeptide and is as strong or stronger than the associations between c-myc and Max or Max and Mxi1. In vitro, Mmip1 can inhibit DNA binding by Max-Mad heterodimers and, in vivo, can reverse the suppressive effects of Mad proteins on c-myc functions. Mmipl is found in a variety of cells types, is induced by serum stimulation, and can be co-immunoprecipitated from fibroblasts in association with Mxi1. By interfering with the dimerization between Max and Mad family member proteins, Mmip1 can indirectly up-regulate the transcriptional activity of c-myc and suppress the antiproliferative actions of Mad proteins.
Collapse
Affiliation(s)
- K Gupta
- Section of Hematology/Oncology, Childrens Hospital of Pittsburgh, Pennsylvania 15213, USA
| | | | | | | | | |
Collapse
|
40
|
Abstract
Dimerization of three Id proteins (Id1, Id2, and Id3) with the four class A E proteins (E12, E47, E2-2, and HEB) and two groups of class B proteins, the myogenic regulatory factors (MRFs: MyoD, myogenin, Myf-5 and MRF4/Myf-6), and the hematopoietic factors (Scl/Tal-1, Tal-2, and Lyl-1) were tested in a quantitative yeast 2-hybrid assay. All three Ids bound with high affinity to E proteins, but a much broader range of interactions was observed between Ids and the class B factors. Id1 and Id2 interacted strongly with MyoD and Myf-5 and weakly with myogenin and MRF4/Myf-6, whereas Id3 interacted weakly with all four MRFs. Similar specificities were observed in co-immunoprecipitation and mammalian 2-hybrid analyses. No interactions were found between the Ids and any of the hematopoietic factors. Each Id was able to disrupt the ability of E protein-MyoD complexes to transactivate from a muscle creatine kinase reporter construct in vivo. Finally, mutagenesis experiments showed that the differences between Id1 and Id3 binding map to three amino acids in the first helix and to a small cluster of upstream residues. The Id proteins thus display a signature range of interactions with all of their potential dimerization partners and may play a role in myogenesis which is distinct from that in hematopoiesis.
Collapse
Affiliation(s)
- K Langlands
- Section of Hematology/Oncology, Children's Hospital of Pittsburgh, The, Pittsburgh, Pennsylvania 15213, USA
| | | | | | | |
Collapse
|
41
|
Anand G, Yin X, Shahidi AK, Grove L, Prochownik EV. Novel regulation of the helix-loop-helix protein Id1 by S5a, a subunit of the 26 S proteasome. J Biol Chem 1997; 272:19140-51. [PMID: 9235903 DOI: 10.1074/jbc.272.31.19140] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023] Open
Abstract
Id proteins negatively regulate the dimerization, DNA binding, and biological properties of basic helix-loop-helix proteins. In a search for novel factors that interact with Id1, we identified a component of the 26 S proteasome, S5a, that has previously been implicated only in the recognition of ubiquitinated polypeptides destined for proteolysis. S5a interacts strongly with Id1, less strongly with the basic helix-loop-helix proteins MyoD and E12, and not at all with other Id proteins. S5a restores DNA binding by MyoD-Id1 and E12-Id1 heterodimers, enhances DNA binding by MyoD and E12 homodimers, and reverses Id1-mediated repression of the muscle creatine kinase promoter during myogenic differentiation. Mutagenesis experiments showed that amino acids flanking the helix-loop-helix domain plus three residues in the first helix of Id1 impart S5a recognition. This requires only the NH2-terminal half of S5a. S5a thus appears to promote the positive regulation of myogenic genes through ubiquitin-independent mechanisms involving inhibition of Id1 and the enhancement of DNA binding by MyoD and E12. This latter property may permit the selection of novel promoter binding sites during myogenesis.
Collapse
Affiliation(s)
- G Anand
- Section of Hematology/Oncology, Department of Pediatrics, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania 15213, USA
| | | | | | | | | |
Collapse
|
42
|
Anand G, Shapiro DN, Dickman PS, Prochownik EV. Rhabdomyosarcomas do not contain mutations in the DNA binding domains of myogenic transcription factors. J Clin Invest 1994; 93:5-9. [PMID: 8282820 PMCID: PMC293710 DOI: 10.1172/jci116982] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023] Open
Abstract
Skeletal myogenesis is regulated by a group of transcription factors (MyoD, myogenin, myf5, and myf6) that are "basic helix-loop-helix" proteins that bind to the promoters of muscle-specific genes and promote their expression. We have previously shown that after a mutation of Leu122 to Arg the DNA binding basic domain of MyoD confers c-myc-like functional characteristics to the protein. In this study we used single-strand conformation polymorphism analysis to determine whether such mutations occur naturally in rhabdomyosarcomas. We have found that the basic domains of all the myogenic factors remain unaltered in rhabdomyosarcomas. Selection against such mutations may be the result of functional redundancy of these myogenic transcription factors.
Collapse
Affiliation(s)
- G Anand
- Department of Pediatrics, Children's Hospital of Pittsburgh, Pennsylvania 15213
| | | | | | | |
Collapse
|